BTG3 and Alzheimer disease: Craig [46] showed that, in a large cohort, the number of diagnoses of AD increased with the titer of ANA (13.3% in low levels to 43.4% in high levels), which is consistent with the present data; diagnosis of AD occurred in 55 (71.14%) patients with high titers of ANA (>1:160).